EXPE vs GMED · P/E 20, rev $7.74B vs P/E 42, rev $1.55B
Expedia Group Inc. (EXPE) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the EXPE and GMED stock pages for the full models.
Not investment advice.